NTRA

Natera Inc.

Price

$265.44

return (12m)

88.17%

p/e

-168.29

p/bv

21.47

DIVIDEND YIELD

0.00%

NTRA price

Natera

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NTRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.10%

3 months

30.28%

1 year

88.17%

2 years

150.18%

5 years

132.84%

10 years

0.00%

Fundamentals NTRA

Valuation

P/E

-168.29

Sector -4.14

Industry -4.14

P/BV

21.47

Sector 2.06

Industry 2.06

P/Revenue (PSR)

15.23

Sector -4.16

Industry -4.16

EV/EBITDA

-580.89

Sector -241.22

Industry -241.22

EV/EBIT

-440.86

Sector -669.95

Industry -669.95

P/EBITDA

-167.25

Sector -4.29

Industry -4.29

P/EBIT

-134.97

Sector -4.34

Industry -4.34

P/Total Assets

14.57

Sector 1.46

Industry 1.46

P/Ativo Circ. Liq.

46.94

Sector -11.90

Industry -11.90

P/Cap.Giro

34.83

Sector -11.81

Industry -11.81

EPS

-1.59

Sector -2.20

Industry -2.20

BVPS

12.49

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

65.07%

Sector 36.35%

Industry 36.35%

EBITDA Margin

-9.14%

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

-12.05%

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

-12.97%

Sector -38.68%

Industry -38.68%

Net Profit Margins

-9.05%

Sector -39.83%

Industry -39.83%

Giro Ativos

0.27

Sector 0.03

Industry 0.03

Profitability

ROE

-12.76%

Sector -66.76%

Industry -66.76%

ROA

-8.66%

Sector -66.63%

Industry -66.63%

ROIC

-31.46%

Sector -2,909.64%

Industry -2,909.64%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.96

Sector 2.90

Industry 2.90

Dívida Líquida/EBITDA

17.08

Sector -11,798,612.26

Industry -11,798,612.26

Dívida Líquida/EBIT

12.96

Sector -3.69

Industry -3.69

Dívida Líquida/Patrimônio

-0.61

Sector -1.12

Industry -1.12

Dívida Bruta/Patrimônio

0.00

Sector 0.00

Industry 0.00

Equity/Assets

0.68

Sector 0.42

Industry 0.42

Liabilities/Assets

0.32

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

31.94%

Sector -

Industry -

5Y Earnings CAGR

-13.66%

Sector -

Industry -

Fundamentals NTRA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
NTRA	-168.29	21.47	-12.76%	0.00%	$38.09 B	-9.05%
JNJ	28.83	0.00	-%	2.08%	$606.58 B	21.48%
PFE	18.76	1.55	8.29%	6.97%	$140.54 B	11.83%
ABBV	125.53	-69.01	-54.98%	2.61%	$456.30 B	5.79%
NVO	11.83	7.14	60.40%	3.68%	$224.33 B	37.15%
MRK	35.53	6.91	19.45%	2.62%	$317.48 B	13.59%
AZN	25.20	5.52	21.93%	1.89%	$261.78 B	17.19%
GILD	18.39	7.23	39.33%	2.36%	$169.47 B	30.99%
BMY	17.03	6.16	36.19%	4.11%	$123.88 B	15.01%
ZTS	12.10	9.90	81.75%	2.72%	$31.99 B	27.79%
REGN	15.93	2.24	14.08%	0.54%	$70.47 B	29.65%
HALO	26.33	41.81	158.82%	0.00%	$9.18 B	23.13%
AMGN	25.48	21.63	84.87%	2.66%	$198.75 B	20.96%
MCK	21.66	-123.68	-570.98%	0.39%	$103.15 B	1.18%
VRTX	28.35	6.35	22.41%	0.00%	$122.99 B	35.51%
CAH	34.90	-20.31	-58.20%	0.89%	$54.27 B	0.62%
HRMY	13.36	2.14	16.00%	0.00%	$1.95 B	16.20%
BIIB	22.13	1.63	7.36%	0.00%	$30.36 B	13.81%
MEDP	32.62	25.10	76.95%	0.00%	$15.02 B	17.19%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NTRA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Natera

Natera Inc.

Average Investor10 user rating

4.0 (9 people)

United States

19 years

Founded: 2007

2015

Time since IPO - 11 years

1.815

Employees

Natera Inc. (United States) is listed on the Nasdaq and has a market capitalization of $38.09 billion, with shareholders equity totaling $1.77 billion.

The company employs approximately 1.815 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Natera Inc. reported $2.50 billion in revenue, generating net income of $-226.31 million.

Key financial metrics include a P/E ratio of -168.29, a price-to-book (P/B) ratio of 21.47, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NTRA.

Market cap

$38.09 billion

Net worth

$1.77 billion

$1,774,020,000.00

Assets

$2.61 billion

$2,614,400,000.00

Total Shares Outstanding

142.00 million

142,000,000

Average Daily Trading Volume

$1.64 million

$1,635,586.00

Sector

Health Care

Industry

Biotechnology

NTRA

revenue by Business Segment Natera

Revenue by Region Natera

NTRA revenue and profits

Financial Results NTRA

DRAG THE FRAME TO SEE MORE DATA

NTRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$842.89 18,89% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$228.84 47,16% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$262.71 60,86% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$131.32 60,15% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$168.59 19,41% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$258.87 41,59% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$49.00 --25,56% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$842.89 18,89% (12 M)

P/L

21.66

0.39%

ROE

-570.98%

P/VP

-123.68

CAH - Cardinal Health

$228.84 47,16% (12 M)

P/L

34.90

0.89%

ROE

-58.20%

P/VP

-20.31

JNJ - Johnson & Johnson

$262.71 60,86% (12 M)

P/L

28.83

2.08%

ROE

P/VP

0.00

MRK - Merck & Co.

$131.32 60,15% (12 M)

P/L

35.53

2.62%

ROE

19.45%

P/VP

6.91

AZN - AstraZeneca

$168.59 19,41% (12 M)

P/L

25.20

1.89%

ROE

21.93%

P/VP

5.52

ABBV - AbbVie

$258.87 41,59% (12 M)

P/L

125.53

2.61%

ROE

-54.98%

P/VP

-69.01

NVO - Novo Nordisk

$49.00 --25,56% (12 M)

P/L

11.83

3.68%

ROE

60.40%

P/VP

7.14

Frequently Asked Questions

What is the price of Natera (NTRA) today?

A cotação de Natera (NTRA) hoje está em US$ 265.44, com uma variação de 88.17% em relação ao último ano. A cotação de Natera (NTRA) iniciou o ano negociando na casa dos US$ 229.09 e hoje está em US$ 265.44. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Natera (NTRA) e dados de ações do Ibovespa e mercados internacionais.

Quando Natera (NTRA) paga dividendos?

Natera (NTRA) não distribuiu dividendos no último ano.

Is Natera (NTRA) a good investment?

Atualmente, Natera (NTRA) está cotada a US$ 265.44, com um P/L de -168.29, representando um desvio de -9,092% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 88.17 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 88.17%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Natera (NTRA) stock?

Investir em ações de Natera (NTRA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Natera (NTRA) yield today?

A rentabilidade de Natera (NTRA) foi de 2.10% no último mês, 88.17% no último ano e 132.84% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Natera (NTRA) hoje, o investimento total seria de US$ 26,544.00, com base na cotação atual de US$ 265.44.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 49,947.84
Em 5 anos: US$ 61,805.05
Em 10 anos: US$ 26,544.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NTRA

Natera Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NTRA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Natera

Natera Inc.

United States

19 years

2015

1.815

PROFIT X PRICE NTRA

Financial Results NTRA

NTRA cash flow

Asset, Revenue and Profit Growth - NTRA

NTRA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions